Sentences with phrase «uncertainty over contract»

With all the uncertainty over contract extensions making the headlines, especially Alexis Sanchez, Mesut Ozil, Oxlade - Chamberlain and, of course, Arsene Wenger, the ex-Arsenal striker Charlie Nicolas believes that we need as much as 5 or 6 arrivals, and he wants Wenger's future clarified as soon as possible.

There have been more than the usual anti-Wenger protests this season, with banners on planes and fighting on the terraces between Arsenal fans, and even Wenger himself admitted that the uncertainty over his contract situation was the cause of the toxic atmosphere and even the form of the players on the pitch.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

After your sales team has agreed upon the contract, it can be easily sent to the vendor and returned — cutting out anguish over previous revisions, as well as the uncertainty of sending a contract via fax or snail mail.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

This news came two months after Boeing similarly lost a contract with Bermuda - based ABS Holding Ltd. and said it would be reducing the work force in its satellite manufacturing business, in part because of uncertainty over the Ex-Im Bank.

Western Australia's largest milk producer plans to triple supply over the next three years, despite the domestic market already struggling with an oversupply and uncertainty surrounding future contracts of some dairy farmers.

Wenger conceded that the negativity he caused over the uncertainty of his contract harmed our performances and thus cost us CL football.

But if Wenger is continuing to hold the negative cloud of uncertainty over his future with the club on purpose in the hope the annual late rally to secure a top 4 spot would justify a new contract then I would rather finish 7th, outside of the European football places allowing a new manager to focus just on the PL and taking any arguments away from Wenger that would delude him into thinking he should continue his unsuccessful reign and the systematic dismantling of our competitive status and DNA.

I believe there is one thing affecting players performance and that is uncertainty... and there are 3 culprits here... ozil and sanchez for holding the club to ransom over their pay demands for a new contract and wenger for not asserting control over the matter.

(1) Our mid-season collapse wasn't just down to «Uncertainty over Wenger's contract» we always have a mid-season collapse, contract talks or not.

The Gunners could find themselves in sixth if Manchester United defeat Middlesbrough, and with the ongoing uncertainty over Wenger's future with his contract set to expire this summer, the atmosphere at the club has certainly become toxic.

After our long period of uncertainty over Le Prof's future, it would seem that the bookies and gamblers are now certain that Wenger will be renewing his contract and he is as short as 1/5 on to stay.

Arsene Wenger admitted that the uncertainty over his new Arsenal contract contributed to our spectacular mid season collapse, which ultimately saw us drop out of the Top Four for the first time under Le Prof, but hopefully that will not be happening again in the next campaign after he penned his new two - year deal.

It's like the uncertainty over Arsene Wenger's contract has made it open season for other clubs to try and poach all our best players this coming summer.

The German international was believed to have entered into talks over a new contract toward the back - end of last season, before stalling amidst uncertainty on the club's ambition.

Ronaldo is under contract at Madrid until 2021, but there is uncertainty over his long - term future amid a stand - off with Perez over a pay - rise and ongoing issues with the Spanish tax authorities.

It is telling he has opted to move to Liverpool for the benefit of his long - term career, despite the huge contract offer from Arsenal, believing his game will develop under Klopp having stalled under Arsene Wenger and uncertainty over his role at Chelsea.

Uncertainty over the shot stopper's future stems from both the short amount of time left on his contract, and United's casual approach to offering an extension.

Arsenal have reportedly decided to start contract talks with a number of first - team players before Christmas in order to avoid the uncertainty over their futures.

Wenger previously admitted the uncertainty over his future had contributed to their struggles but he batted away further questions about a new contract on Wednesday.

Evans, 29, currently has two years left on his Baggies contract, but he has yet to reopen talks over a suitable extension amid the uncertainty over his future at the Hawthorns.

Most districts with teacher contracts extended them for one year last spring because of the uncertainty during the debate over the state's new collective bargaining law, said Miles Turner, executive director of the Wisconsin Association of School District Administrators.

After Congress, FEMA, and citizens throughout the US raised concerns about a $ 300 million contract to rebuild Puerto Rico's energy grid following last month's storm, Puerto Rico's governor, Ricardo A. Rosselló, cancelled the arrangement over the weekend, adding further uncertainty to the island's recovery efforts.